Post

Related News

"Risky Behavior" Side Effect Explained
Researchers may have figured out why some PD patients develop impulsive-compulsive spectrum behaviors (ICBs), such as gambling, as a side effect of their medications. The scientists found that PD ... 
20 Jul 2010
Research News
Induced Pluripotent Stem Cells Remember Their Origins
In two recent papers, scientists from independent labs report that induced pluripotent stem cells (iPSCs) retain at least a partial epigenetic memory of their origin. So, if an iPSC line originated ... 
20 Jul 2010
Research News
Parkinson's Drug Dropped Based on Preclinical Tox Studies
Vernalis and Biogen have decided to stop working on vipadenant after reviewing preclinical toxicology studies involving the drug, despite positive data coming out of Phase II clinical trials. The ... 
16 Jul 2010
Business News
Getting around Stem Cell Complications
As researchers at UC San Diego report in the Proceedings of the National Academy of Sciences, they have discovered a new signaling mechanism by which embryonic stem cells can propagate. The finding ... 
12 Jul 2010
Research News
Patent Granted for Method to Break through Blood-Brain Barrier
It's notoriously difficult to move molecules past the blood-brain barrier (BBB). Adding a little mannitol might help, however. The University of South Florida's Department of Neurosurgery and Brain ... 
12 Jul 2010
Business News
New PD models available through MJFF-Jackson Labs partnership
The Michael J. Fox Foundation is expanding its efforts through a partnership with The Jackson Laboratory to make pre-clinical models more widely available to the research community. It is essential ... 
01 Feb 2010
Funding News, MJFF Funded Projects: Abstracts, Progress, and Outcomes, Research News
Responses: 3
New Analysis Predicts High Demand for Neurostimulation Technologies
Frost & Sullivan says that the market for neurostimulation technologies, such as deep-brain stimulation, is “under penetrated”. And the demand for these technologies will only ... 
30 Jun 2010
Business News
Wired magazine features an article about Sergey Brin’s investments in Parkinson’s research
The article discusses Brin’s contributions to 23andMe, PD biomarkers and LRRK2 research, including mention of MJFF’s LRRK2 Biology Consortium.  ... 
23 Jun 2010
Neurologix Announces Positive Results of a Phase II Gene Therapy Trial for PD
This is the first ever report of a successful Phase II gene therapy trial for PD.  ... 
22 Jun 2010
Drugmakers to share data to speed brain drug research
WASHINGTON (Reuters/By Lisa Richwine) - Major drugmakers will share data from their clinical trials for Alzheimer's and Parkinson's disease in an effort to speed the development of new medicines ... 
11 Jun 2010
Clinical Trial News